SCHEMBL515746

SCHEMBL515746

CCC(=O)c1ccc(OC)c(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.73
KMT2A Q03164 2/20 0.73
KDM4E B2RXH2 1/20 0.69
SMN1; SMN2 Q16637 2/20 0.68
HPGD P15428 2/20 0.68
NPC1 O15118 1/20 0.68
RAB9A P51151 1/20 0.68
TSHR P16473 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
CYP2C9 P11712 2/20 0.66
CYP2C19 P33261 2/20 0.66
MAPT P10636 3/20 0.65
CTNNB1 P35222 2/20 0.65
WNT3A P56704 2/20 0.65
CA12 O43570 1/20 0.63
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
CA4 P22748 1/20 0.63
CA6 P23280 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29578705 1.00 MEN1 (0.73) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL29175063 0.91 MEN1 (0.68) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL15202688 0.90 MAPK1 (0.67) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL15054856 0.87 MEN1 (0.62) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL25139577 0.87 MEN1 (0.62) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL661011 0.87 PDE4B (0.62) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL1659363 0.86 MAPT (0.71) MEN1KMT2ASMN1; SMN2TSHRCYP1A2
SCHEMBL10455919 0.86 CTNNB1 (0.83) MEN1KMT2ASMN1; SMN2TSHRCYP1A2
SCHEMBL31374780 0.85 KDM4E (0.70) MEN1KMT2AKDM4ESMN1; SMN2HPGD
SCHEMBL4668902 0.85 MEN1 (0.89) MEN1KMT2AKDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3661902-B1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIV ANTWERPEN (BE) 2025-07-16 EP claimed
US-20240400784-A1 Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition LG CHEM, LTD. (KR) 2024-12-05 US claimed
US-20240392094-A1 Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition LG CHEM, LTD. (KR) 2024-11-28 US claimed
CN-117897439-A Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition 株式会社LG化学 2024-04-16 CN claimed
CN-117897440-A Method for screening solvent for extraction of polyvinyl chloride, method for recycling waste material, recycled polyvinyl chloride and composition 株式会社LG化学 2024-04-16 CN claimed
WO-2023033605-A1 METHOD FOR SCREENING SOLVENT FOR EXTRACTING POLYVINYL CHLORIDE, METHOD FOR RECYCLING WASTE, RECYCLED POLYVINYL CHLORIDE, AND COMPOSITION 주식회사 엘지화학 2023-03-09 WO claimed
WO-2023033601-A1 METHOD FOR SCREENING SOLVENT FOR POLYVINYL CHLORIDE EXTRACTION, RECYCLING METHOD FOR WASTE MATERIAL, AND RECYCLED POLYVINYL CHLORIDE AND COMPOSITION 주식회사 엘지화학 2023-03-09 WO claimed
CN-114751576-A Method for treating dialkoxybenzene production wastewater 北京惠宇乐邦环保科技有限公司 2022-07-15 CN claimed
US-20210130273-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2021-05-06 US claimed
CN-111542509-A Method for deacylation and/or dealkylation of compounds 安特卫普大学 2020-08-14 CN claimed
EP-3661902-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS Universiteit Antwerpen (BE) 2020-06-10 EP claimed
WO-2019025535-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIVERSITEIT ANTWERPEN (BE) 2019-02-07 WO claimed
CN-105494381-A Pesticide for prevention and control of callosobruchus maculatus YANTAI SHUNLONG CHEMICAL TECH CO LTD 2016-04-20 CN claimed
CN-103435507-B Preparation method of L-alpha-methyl-3,4-dihydroxyphenylalanine SHANDONG XINHUA PHARMACEUTICAL 2015-03-25 CN claimed
CN-103435507-A Preparation method of L-alpha-methyl-3,4-dihydroxyphenylalanine SHANDONG XINHUA PHARMACEUTICAL 2013-12-11 CN claimed
EP-3661902-B1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS UNIV ANTWERPEN (BE) 2025-07-16 EP disclosed
US-20240400784-A1 Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition LG CHEM, LTD. (KR) 2024-12-05 US disclosed
US-3969410-A SYMPATHOMIMETICS BOEHRINGER INGELHEIM GMBH (DT) 1976-07-13 US disclosed
US-3962247-A ANGINA PECTORIS FUJI CHEMICAL INDUSTRY CO., LTD. (JA) 1976-06-08 US disclosed
US-3948899-A CEREBRAL AND CORONARY CIRCULATION FUJI CHEMICAL INDUSTRY CO., LTD. (JA) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130273-A1 METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS HAAO, TDO2, HPD MEN1 3750/4885KMT2A 1208/4885KDM4E 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.